Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review

References

• Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers. 2018;4(1):21–44.
   PubMed Web of Science ®Google Scholar
• Fatemi N, Sarkar B. Molecular mechanism of copper transport in Wilson disease. Environ Health Prospect. 2002;110(suppl 5):695–698.
   PubMedGoogle Scholar
• Gromadzka G, Schmidt HHJ, Genschel J, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet. 2005;68(6):524–532.
   PubMed Web of Science ®Google Scholar
• Gromadzka G, Schmidt HHJ, Genschel J, et al. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease. Mov Disord. 2006;21(2):245–248.
   PubMed Web of Science ®Google Scholar
• Kumar S, Thapa B, Kaur G, et al. Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper ATPase activity. Mol Cell Biochem. 2007;294(1–2):1–10.
   PubMed Web of Science ®Google Scholar
• Stapelbroek JM, Bollen CW, van Amstel JK, et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol. 2004;41(5):758–763.
   PubMed Web of Science ®Google Scholar
• Vrabelova S, Letocha O, Borsky M, et al. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Mol Genet Metab. 2005;86(1–2):277–285.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhu K, Wang J, et al. Relationship between genetic mutations and clinical phenotypes in patients with Wilson disease. Medicine (Baltimore). 2019;98(49):e18284.
   PubMed Web of Science ®Google Scholar
• Dzieżyc K, Litwin T, Chabik G, et al. Families with Wilson's disease in subsequent generations: clinical and genetic analysis. Mov Disord. 2014;29(14):1828–1832.
   PubMed Web of Science ®Google Scholar
• Członkowska A, Rodo M, Gromadzka G. Late onset Wilson's disease: therapeutic implications. Mov Disord. 2008;23(6):896–898.
   PubMed Web of Science ®Google Scholar
• Członkowska A, Gromadzka G, Chabik G. Monozygotic female twins discordant for phenotype of Wilson's disease. Mov Disord. 2009;24(7):1066–1069.
   PubMed Web of Science ®Google Scholar
• Gromadzka G, Rudnicka M, Chabik G, et al. Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease. J Hepatol. 2011;55(4):913–919.
   PubMed Web of Science ®Google Scholar
• Gromadzka G, Członkowska A. Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson's disease. Int J Neurosci. 2011;121(1):8–15.
   PubMed Web of Science ®Google Scholar
• Merle U, Stremmel W, Reinhard G. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol. 2006;63(7):982–985.
   PubMedGoogle Scholar
• Gu YH, Kodama H, Du SL. Apolipoprotein E genotype analysis in Chinese Han ethnic children with Wilson's disease, with a concentration on those homozygous for R778L. Brain Dev. 2005;27(8):551–553.
   PubMed Web of Science ®Google Scholar
• Litwin T, Gromadzka G, Członkowska A. Apolipoprotein E gene (APOE) genotype in Wilson’s disease: Impact on clinical presentation. Parkinsonism Relat Disord. 2012;18(4):367–369.
   PubMed Web of Science ®Google Scholar
• Wang XP, Wang XH, Bao YC, et al. Apolipoprotein E genotypes in Chinese patients with Wilson's disease. QJM. 2003;96(7):541–544.
   PubMed Web of Science ®Google Scholar
• Roy S, Ganguly K, Pal P, et al. Influence of apolipoprotein E polymorphism on susceptibility of Wilson disease. Ann Hum Genet. 2018;82(2):53–59.
   PubMed Web of Science ®Google Scholar
• Gromadzka G, Kruszyńska M, Wierzbicka D, et al. Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease. Liver Int. 2015;35(1):215–222.
   PubMed Web of Science ®Google Scholar
• Stättermayer AF, Traussnigg S, Dienes HP, et al. Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations. J Hepatol. 2015;63(1):156–163.
   PubMed Web of Science ®Google Scholar
• Ferenci P, Pfeiffenberger J, Stättermayer AF, et al. HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's disease. JHEP Rep. 2019;1(1):2–8.
   PubMedGoogle Scholar
• Ferenci P, Stremmel W, Członkowska A, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease. Hepatology 2019;69(4):1464–1476.
   PubMed Web of Science ®Google Scholar
• Chandarana H, Lim RP, Jensen JH, et al. Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence. Am J Roentgenol. 2009;193(5):1261–1267.
   PubMed Web of Science ®Google Scholar
• Hafkemeyer P, Schupp M, Storch M, et al. Excessive iron storage in a patient with Wilson's disease. Clin Investig. 1994;72(2):134–136.
   PubMedGoogle Scholar
• Litwin T, Gromadzka G, Szpak GM, et al. Brain metal accumulation in Wilson's disease. J Neurol Sci. 2013;329(1–2):55–58.
   PubMed Web of Science ®Google Scholar
• Dusek P, Bahn E, Litwin T, et al. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI – Histopathological study. Neuropathol Appl Neurobiol. 2017;43(6):514–532.
   PubMed Web of Science ®Google Scholar
• Litwin T, Gromadzka G, Członkowska A. Wilson's disease: does iron metabolism impact phenotypic presentation? Liver Int. 2012;32(5):869–870.
   PubMed Web of Science ®Google Scholar
• Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene. 2015;574(2):179–192.
   PubMed Web of Science ®Google Scholar
• Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica. 2017;102(5):809–817.
   PubMed Web of Science ®Google Scholar
• Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23(3):139–142.
   PubMed Web of Science ®Google Scholar
• Ravin HA. An improved colorimetric assay of ceruloplasmin. J Lab Clin Med. 1961;58:161–168.
   PubMed Web of Science ®Google Scholar
• Settin A, El-Bendary M, Abo-Al-Kassem R, et al. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis. J Gastrointestin Liver Dis. 2006;15:131–135.
   PubMedGoogle Scholar
• Merryweather-Clarke AT, Shearman JD, Robson KJ, et al. Hemochromatosis-related mutation detection. Blood. 1998;91(7):2620–2621.
   PubMed Web of Science ®Google Scholar
• Rahmani FA, Schengrund CL, Connor JR. HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease. Pharmacology. 2014;5:1–19.
   Web of Science ®Google Scholar
• Waheed A, Grubb JH, Zhou XY, et al. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA. 2002;99(5):3117–3122.
   PubMed Web of Science ®Google Scholar
• Erhardt A, Hoffmann A, Hefter H, et al. HFE gene mutations and iron metabolism in Wilson's disease. Liver. 2002;22(6):474–478.
   PubMedGoogle Scholar
• Sorbello O, Sini M, Civolani A, et al. HFE gene mutations and Wilson’s disease in Sardinia. Digest Liver Dis. 2010;42(3):216–219.
   Web of Science ®Google Scholar
• Kelley M, Joshi N, Xie Y, et al. Iron overload is rare in patients homozygous for the H63D mutation. Can J Gastroenterol Hepatol. 2014;28(4):198–202.
   PubMed Web of Science ®Google Scholar
• Neghina AM, Anghel A. Hemochromatosis genotypes and risk of iron overload – A meta-analysis. Ann Epidemiol. 2011;21(1):1–14.
   PubMed Web of Science ®Google Scholar
• Soltanpour MS, Davari K. The correlation of cardiac and hepatic hemosiderosis as measured by T2*MRI technique with ferritin levels and hemochromatosis gene mutations in Iranian patients with beta thalassemia major. Oman Med J. 2018;33(1):48–54.
   PubMedGoogle Scholar
• Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol. 2001;154(3):193–206.
   PubMed Web of Science ®Google Scholar
• Carru C, Pes GM, Deiana L, et al. Association between the HFE mutations and longevity: a study in Sardinian population. Mech Ageing Dev. 2003;124(4):529–532.
   PubMed Web of Science ®Google Scholar
• Santos PC, Cançado RD, Terada CT, et al. HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol Res. 2010;43(1):107–114.
   PubMed Web of Science ®Google Scholar
• Walshe JM, Cox DW. Effect of treatment of Wilson’s disease on natural history of hemochromatosis. Lancet. 1998;352(9122):112–113.
   PubMed Web of Science ®Google Scholar
• Dib N, Valsesia E, Malinge MC, et al. Late onset of Wilson's disease in a family with genetic haemochromatosis. Eur J Gastroenterol Hepatol. 2006;18:43–47.
   PubMed Web of Science ®Google Scholar
• Pfeiffenberger J, Gotthardt DN, Herrmann T, et al. Iron metabolism and the role of HFE gene polymorphism in Wilson disease. Liver Int. 2012;32(1):165–170.
   PubMed Web of Science ®Google Scholar